NCT00480688View on ClinicalTrials.gov

A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

May 31, 2002

Conditions
TB
Interventions
BIOLOGICAL

BCG

Trial Locations (1)

OX3 7LJ

University of Oxford, CCVTM, Churchill Hospital, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT00480688 - A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers | Biotech Hunter | Biotech Hunter